NervGen Pharma Corp. Common stock (NGEN) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−22.3x

Market Cap

$250.53M

MomentumView details →

1D Return

+0.43%

YTD Return

−57.86%

RSI (14)

73.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−22.3x

Market Cap

$250.53M

RSI (14)

73.4

MomentumView details →

1D Return

+0.43%

YTD Return

−57.86%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−390.39%

ROA (TTM)

−74.79%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−69.44%

EBITDA YoY

+49.35%

EarningsView details →

EPS (Actual)

−$0.37

EPS Surprise

−510.76%

Beats (12Q)

1/12

Next Q EPS Est

−$0.07

Avg Surprise (4Q)

−198.51%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.23x

Quick Ratio

1.23x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−67.56M

Op. CF (TTM)

−29.60M

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for NGEN.

Similar companies

YD Bio Limited Ordinary SharesYDES Niagen Bioscience IncNAGE Veraxa Biotech Holding AGVRXA Neumora Therapeutics, Inc. Common StockNMRA Eledon Pharmaceuticals, Inc.ELDN Compugen Ltd.CGEN Find similar companies →

Latest newsMore news →

No recent news for NGEN.